Tuesday, August 05, 2025 8:20:58 AM
💥🚀 https://www.cannabisbusinesstimes.com/hemp/news/15751847/us-senate-pulls-hemp-thc-ban-provision-from-ag-spending-bill
https://www.barchart.com/stocks/quotes/CVSI/opinion
https://www.researchgate.net/profile/Hemank-Kc/publication/392015584_Phytochemical_screening_and_evaluation_of_Antimicrobial_and_Antioxidant_activity_of_Cannabis_sativa_leaves_extract/links/68306df78a76251f22e5fb67/Phytochemical-screening-and-evaluation-of-Antimicrobial-and-Antioxidant-activity-of-Cannabis-sativa-leaves-extract.pdf?__cf_chl_tk=2qcUmXFCpA3IHBjZ1aWaYNgWVcHrY0lxoS_TvuEX02U-1754394538-1.0.1.1-p1hUsajgBCeisT3mgkMprQtEuPPZVCI5_cKNYp53Q_A
https://link.springer.com/article/10.1007/s00284-025-04379-8
https://www.barchart.com/stocks/quotes/CVSI/opinion
https://www.researchgate.net/profile/Hemank-Kc/publication/392015584_Phytochemical_screening_and_evaluation_of_Antimicrobial_and_Antioxidant_activity_of_Cannabis_sativa_leaves_extract/links/68306df78a76251f22e5fb67/Phytochemical-screening-and-evaluation-of-Antimicrobial-and-Antioxidant-activity-of-Cannabis-sativa-leaves-extract.pdf?__cf_chl_tk=2qcUmXFCpA3IHBjZ1aWaYNgWVcHrY0lxoS_TvuEX02U-1754394538-1.0.1.1-p1hUsajgBCeisT3mgkMprQtEuPPZVCI5_cKNYp53Q_A
https://link.springer.com/article/10.1007/s00284-025-04379-8
Bullish
Recent CVSI News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 08:04:10 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 09:14:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 08:06:03 PM
- CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results • ACCESS Newswire • 03/26/2026 08:00:00 PM
- CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026 • ACCESS Newswire • 03/24/2026 09:00:00 PM
- CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth • ACCESS Newswire • 03/10/2026 09:00:00 PM
- CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness • ACCESS Newswire • 02/26/2026 01:30:00 PM
- CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD • ACCESS Newswire • 12/23/2025 12:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 10:19:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 09:04:08 PM
- CV Sciences, Inc. Reports Third Quarter 2025 Financial Results • ACCESS Newswire • 11/13/2025 09:00:00 PM
- CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025 • ACCESS Newswire • 11/10/2025 11:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2025 09:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:24:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 09:23:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2025 08:01:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2025 08:50:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2025 08:01:33 PM
